Heidelberg Pharma AG

XTRA:HPHA Rapporto sulle azioni

Cap. di mercato: €121.2m

Heidelberg Pharma Gestione

Gestione criteri di controllo 2/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Andreas Pahl

Amministratore delegato

€450.7k

Compenso totale

Percentuale dello stipendio del CEO53.3%
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del management1.7yrs
Durata media del Consiglio di amministrazione12.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Heidelberg Pharma (ETR:HPHA) A Risky Investment?

Feb 16
Is Heidelberg Pharma (ETR:HPHA) A Risky Investment?

Heidelberg Pharma AG's (ETR:HPHA) Price In Tune With Revenues

Dec 05
Heidelberg Pharma AG's (ETR:HPHA) Price In Tune With Revenues

Industry Analysts Just Upgraded Their Heidelberg Pharma AG (ETR:HPHA) Revenue Forecasts By 21%

Jul 21
Industry Analysts Just Upgraded Their Heidelberg Pharma AG (ETR:HPHA) Revenue Forecasts By 21%

Analyst Forecasts For Heidelberg Pharma AG (ETR:HPHA) Are Surging Higher

Oct 16
Analyst Forecasts For Heidelberg Pharma AG (ETR:HPHA) Are Surging Higher

Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely

Nov 28
Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely

Heidelberg Pharma AG (ETR:HPHA) Analysts Are More Bearish Than They Used To Be

Mar 27
Heidelberg Pharma AG (ETR:HPHA) Analysts Are More Bearish Than They Used To Be

We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Mar 15
We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Investors Who Bought Heidelberg Pharma (ETR:HPHA) Shares Five Years Ago Are Now Up 245%

Jan 17
Investors Who Bought Heidelberg Pharma (ETR:HPHA) Shares Five Years Ago Are Now Up 245%

We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Dec 14
We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Andreas Pahl rispetto agli utili di Heidelberg Pharma?
DataCompenso totaleStipendioGuadagni aziendali
Aug 31 2024n/an/a

-€19m

May 31 2024n/an/a

-€13m

Feb 29 2024n/an/a

-€18m

Nov 30 2023€451k€240k

-€20m

Aug 31 2023n/an/a

-€22m

May 31 2023n/an/a

-€27m

Feb 28 2023n/an/a

-€19m

Nov 30 2022€328k€240k

-€20m

Aug 31 2022n/an/a

-€21m

May 31 2022n/an/a

-€22m

Feb 28 2022n/an/a

-€27m

Nov 30 2021€442k€240k

-€26m

Aug 31 2021n/an/a

-€25m

May 31 2021n/an/a

-€22m

Feb 28 2021n/an/a

-€20m

Nov 30 2020€295k€207k

-€18m

Aug 31 2020n/an/a

-€17m

May 31 2020n/an/a

-€15m

Feb 29 2020n/an/a

-€12m

Nov 30 2019€288k€200k

-€10m

Aug 31 2019n/an/a

-€10m

May 31 2019n/an/a

-€11m

Feb 28 2019n/an/a

-€12m

Nov 30 2018€286k€200k

-€12m

Aug 31 2018n/an/a

-€11m

May 31 2018n/an/a

-€11m

Feb 28 2018n/an/a

-€11m

Nov 30 2017€241k€171k

-€11m

Compensazione vs Mercato: Andreas's total compensation ($USD491.78K) is about average for companies of similar size in the German market ($USD488.36K).

Compensazione vs guadagni: Andreas's compensation has increased whilst the company is unprofitable.

AMMINISTRATORE DELEGATO

Andreas Pahl

less than a year

Mandato

€450,663

Compensazione

Prof. Dr. Andreas Pahl is Chief Executive Officer & Spokesman of the Executive Board at Heidelberg Pharma AG since February 1, 2024 and had been its Chief Scientific Officer and Member of the Executive Man...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Andreas Pahl
CEO & Spokesman of the Executive Boardless than a year€450.66kNessun dato
Walter Miller
Chief Financial Officer1.5yrs€398.63kNessun dato
Jorg Kemkowski
Chief Operating Officer1.8yrsNessun datoNessun dato
Sylvia Wimmer
Director Corporate Communicationno dataNessun datoNessun dato
Andras Strassz
Chief Medical Officer3.7yrsNessun datoNessun dato
George Badescu
Chief Business Officerno dataNessun datoNessun dato

1.7yrs

Durata media

Gestione esperta: HPHA's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Friedrich von Bohlen und Halbach
Member of the Supervisory Board19.6yrs€18.00kNessun dato
Georg Baur
Deputy Chairman of the Supervisory Board24.8yrs€38.00kNessun dato
Christof Hettich
Chairman of Supervisory Board14.5yrs€49.50kNessun dato
Birgit Kudlek
Member of the Supervisory Board12.5yrs€21.75kNessun dato
Mathias Hothum
Deputy Chairman of Supervisory Board9.3yrs€39.00kNessun dato
Dongzhou Liu
Member of Supervisory Board2.4yrs€21.00kNessun dato
Yan Xia
Member of Supervisory Board1.5yrs€9.96kNessun dato

12.5yrs

Durata media

59.5yo

Età media

Consiglio di amministrazione esperto: HPHA's board of directors are seasoned and experienced ( 12.5 years average tenure).